Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company
creating innovative personalized therapeutics for patients with
genetically defined cancers, announced today that it will host a
conference call and live audio webcast on Wednesday, August 13, 2014 at
8:00 a.m. ET to report second quarter 2014 financial results and provide
a corporate update.
for Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014 investment picks